Additionally, Su-Dhl-4 cells treated with entinostat or tazemetostat also showed downregulation of RAD51, RAD54L, BRCA2, and three Fanconi anemia genes (FANCA, FANCB, and FANCM). This evidence concerns the gene FANCB and Fanconi anemia.